NasdaqGS:ASNDBiotechs
Is Ascendis Pharma (ASND) Still Attractive After Its Strong Multi Year Share Price Run?
If you are wondering whether Ascendis Pharma's share price still reflects fair value after its recent run, this article will walk through what the numbers are saying right now.
The stock last closed at US$216.32, with returns of 5.1% over the past 30 days and 50.1% over the past year, while the 7-day return of a 2.6% decline shows the ride has not been perfectly smooth.
Recent moves sit against a backdrop of ongoing interest in Ascendis Pharma as a Nasdaq-listed pharmaceuticals and biotech...